Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "Microbial cell membrane disruption by released silver ion" refers to a well-characterized mode of action, not to a discrete molecular target or receptor. Silver ions (Ag^+) released from silver-containing compounds or nanoparticles interact with microbial (bacterial) cell membranes by adhering to and penetrating the membrane, thereby increasing membrane permeability and disrupting its integrity[1][3][4][5]. This leads to loss of vital ions (e.g., potassium), leakage of metabolites, depolarization, and impairment of ATP synthesis. Silver ions also interact with sulfur-containing proteins and nucleic acids inside the cell, causing additional cellular dysfunction through enzyme inhibition, protein denaturation, and ROS generation, ultimately leading to cell death[1][4][5][6]. While the microbial cell membrane is the major structural target affected, it is not a druggable protein or biomolecular entity, but rather a functional site or process targeted by silver ions. Note on suitability as a target: "Microbial cell membrane disruption by released silver ion" is not a canonical molecule or receptor but is instead a descriptive process/mechanism. Standard target naming conventions focus on defined molecules (e.g., enzymes, channels, receptors) rather than entire cellular structures or mechanistic events. If a more structured target is required for data consistency, consider annotating the "microbial cell membrane" or specific membrane proteins (e.g., porins like OmpF/OmpC in E. coli[2][4]) as the direct molecular target.
Disruption of microbial cell membrane integrity by released silver ions (Ag^+) Increased membrane permeability leading to leakage of cellular contents Depolarization of membrane potential Inhibition and denaturation of membrane-bound enzymes Generation of reactive oxygen species (ROS) leading to oxidative damage Interaction with membrane proteins (e.g. OmpF and OmpC)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cell membrane.